Vendor hopes for executive stability Israeli technology firm Elbit has named Thomas Bird to head ElbitUltrasound Group, the company's far-flung empire of ultrasoundfirms that includes Diasonics and Ausonics. Bird will fill theleadership vacuum
Israeli technology firm Elbit has named Thomas Bird to head ElbitUltrasound Group, the company's far-flung empire of ultrasoundfirms that includes Diasonics and Ausonics. Bird will fill theleadership vacuum left by Diasonics CEO Bruce Moore, who leftthe company earlier this year (SCAN 2/15/95).
Elbit hopes Bird's arrival will put an end to speculation aboutits ultrasound leadership team, particularly in the executivesuites of Diasonics. After Moore's departure in January, ElbitCEO Emmanuel Gill stepped in to take Moore's place and promotedseveral executives at Diasonics headquarters in Santa Clara, CA.However, one of those executives, Omar Ishrak, left Diasonicsin May to head up the ultrasound business of GE Medical Systems(SCAN 6/7/95).
Bird has executive authority not only over Diasonics but alsoover the other companies in Elbit Ultrasound Group, which includesSonotron, Vingmed Sound, Ausonics and Elscintec. Bird will reportdirectly to Gill.
Bird comes to Diasonics from the consulting world. He was presidentand CEO of Management Concepts, a Los Angeles consulting firm,and specialized in the management of large global organizations.His ultrasound experience includes three years with Philips UltrasoundInternational.
Bird's goals will be to increase the group's market share inradiology and cardiology and to expand the company's presencein new market segments. For example, Diasonics recently forgeda link with sister company Elscint to increase its market penetrationin Canada. The deal essentially quadruples the number of salesreps selling Diasonics scanners in Canada.
Elbit Ultrasound Group hired Bird because it determined thata leadership presence was needed near Diasonics headquarters,according to David Kaufman, Diasonics vice president of salesand service for North America.
"For a day-to-day focus on the operations of the business,there needed to be somebody nearby," Kaufman said. "Wefelt we needed to have someone more closely allied with the organizationwith a full focus on the company."
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.